-
(单词翻译:双击或拖选)
Supreme1 Court ruling on mifepristone causes uncertainty2 for advocates
Activists4 on both sides of the abortion5 issue are awaiting a Supreme Court decision on the medication mifepristone, used in more than half of the abortions6 in the U.S. It is also used in miscarriage7 management.
How did we get here?
Mifepristone was called into question on April 7, when U.S. District Judge Matthew Kacsmaryk imposed a nationwide ban, saying the Food and Drug Administration (FDA) had improperly8 approved mifepristone 23 years ago. Within minutes, a judge in Washington state, U.S. District Judge Thomas Rice, issued a contrary ruling directing federal authorities not to make any changes in mifepristone access in at least 17 states where Democrats9 had sued to protect availability. Five days later, the 5th Circuit Court of Appeals narrowed Kacsmaryk's ruling. It declared that the time had passed for challenging the original FDA approval, but it also tightened10 the agency's window for using the drug from 10 weeks, as approved in 2016, to seven weeks.
The Biden administration asked the U.S. Supreme Court to preserve access to mifepristone. And the high court temporarily paused lower court rulings while setting the Friday deadline to decide whether to let any restrictions11 take effect.
Advocates cite one study to counter a green light from FDA
An attorney for an advocacy group that filed an amicus brief on behalf of parties suing for mifepristone restrictions argues that the drug declared "safe and effective" by the FDA is dangerous. Attorney Chelsey Youman, who represents Human Coalition12, tells Morning Edition that despite 23 years of study and repeated reviews, the FDA has not fully13 accounted for possible complications.
In an interview with NPR's Michel Martin, Youman cites a single advocacy study of post-abortion emergency room visits that suggested an ER visit was more likely within 30 days of a medication procedure. "We're serving these women, sometimes in the middle of their abortions, calling us, panicking about what they're experiencing and what their bodies are experiencing," she says.
Since mifepristone was first approved by the FDA in 2000, the drug has been used for abortions by more than 5 million women in the U.S. A study from KFF, an independent health policy organization, determined14 that medication abortion successfully terminates pregnancy15 99.6% of the time. The foundation found a .4% risk of major complications and a mortality rate of less than .001%.
The FDA issued its most recent summary report of adverse16 events in June 2022, saying it "did not identify any new safety signals."
Youman, whose group aims to eliminate abortion in the U.S., contends that the number of women requiring emergency follow-up care is "astronomical17."
"That doesn't even include the FDA not requiring reporting of adverse events," Youman says, adding, "It's not safe for women."
Court rulings prompt anxiety and uncertainty
Dr. Audrey Lance, an OB-GYN with Northland Family Planning near Detroit, told Michigan Radio's Kate Wells that conflicting legal rulings and the wait for answers is complicating18 care and making it difficult to help patients.
"Am I allowed to do that? I don't know yet," Lance tells NPR. "I don't know what's going to happen."
Whether there's any consensus19 among justices on the high court is also unclear, as NPR legal affairs correspondent Nina Totenberg tells All Things Considered. "If there was a clear consensus on this at the court, I think the justices would have acted [earlier]."
Totenberg points to the early days of the pandemic, when some abortion rights activists were trying to ease restrictions on access to abortion pills. Then, conservatives on the Supreme Court deferred20 to the FDA's expertise21. Justice Samuel Alito, who would later author the decision overturning the landmark22 Roe23 v. Wade24 abortion protections, expressed amazement25 in 2020 that a district court judge in Maryland "took it upon himself to overrule the FDA on a question of drug safety."
1 supreme | |
adj.极度的,最重要的;至高的,最高的 | |
参考例句: |
|
|
2 uncertainty | |
n.易变,靠不住,不确知,不确定的事物 | |
参考例句: |
|
|
3 transcript | |
n.抄本,誊本,副本,肄业证书 | |
参考例句: |
|
|
4 activists | |
n.(政治活动的)积极分子,活动家( activist的名词复数 ) | |
参考例句: |
|
|
5 abortion | |
n.流产,堕胎 | |
参考例句: |
|
|
6 abortions | |
n.小产( abortion的名词复数 );小产胎儿;(计划)等中止或夭折;败育 | |
参考例句: |
|
|
7 miscarriage | |
n.失败,未达到预期的结果;流产 | |
参考例句: |
|
|
8 improperly | |
不正确地,不适当地 | |
参考例句: |
|
|
9 democrats | |
n.民主主义者,民主人士( democrat的名词复数 ) | |
参考例句: |
|
|
10 tightened | |
收紧( tighten的过去式和过去分词 ); (使)变紧; (使)绷紧; 加紧 | |
参考例句: |
|
|
11 restrictions | |
约束( restriction的名词复数 ); 管制; 制约因素; 带限制性的条件(或规则) | |
参考例句: |
|
|
12 coalition | |
n.结合体,同盟,结合,联合 | |
参考例句: |
|
|
13 fully | |
adv.完全地,全部地,彻底地;充分地 | |
参考例句: |
|
|
14 determined | |
adj.坚定的;有决心的 | |
参考例句: |
|
|
15 pregnancy | |
n.怀孕,怀孕期 | |
参考例句: |
|
|
16 adverse | |
adj.不利的;有害的;敌对的,不友好的 | |
参考例句: |
|
|
17 astronomical | |
adj.天文学的,(数字)极大的 | |
参考例句: |
|
|
18 complicating | |
使复杂化( complicate的现在分词 ) | |
参考例句: |
|
|
19 consensus | |
n.(意见等的)一致,一致同意,共识 | |
参考例句: |
|
|
20 deferred | |
adj.延期的,缓召的v.拖延,延缓,推迟( defer的过去式和过去分词 );服从某人的意愿,遵从 | |
参考例句: |
|
|
21 expertise | |
n.专门知识(或技能等),专长 | |
参考例句: |
|
|
22 landmark | |
n.陆标,划时代的事,地界标 | |
参考例句: |
|
|
23 roe | |
n.鱼卵;獐鹿 | |
参考例句: |
|
|
24 wade | |
v.跋涉,涉水;n.跋涉 | |
参考例句: |
|
|
25 amazement | |
n.惊奇,惊讶 | |
参考例句: |
|
|